Vaccinations
Cancer Vaccines
Preclinical Development: Overview
Development of Immunocompetence
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 26, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Karl Ljungberg1, Maria Isaguliants2,3,4,5
1Eurocine Vaccines AB, Fogdevreten 2, 17165 Solna, Sweden.
DNA vaccines are a versatile platform for developing treatments against cancer and various infectious and noninfectious diseases. This technology offers a promising avenue for future therapeutic strategies.
Area of Science:
Background: